A Win For Veru Inc.
Veru Inc. (VERU:NASDAQ) rocketted at $14.44, a gain of 39.5%. On Mon, Nov 07, 2022, VERU:NASDAQ touched a New 2-Week High of $14.44. The stock appeared on our News Catalysts scanner on Mon, Nov 07, 2022 at 04:48 PM in the 'BIOTECH' category. From Mon, Oct 24, 2022, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Aug 17, 2022 at $24.55 with a volume of 12M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Creatd Inc. (CRTD:NASDAQ), 48.39%
- Arqit Quantum Inc. (ARQQ:NASDAQ), 46.87%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Veru Inc. (VERU:NASDAQ), 39.52%
- Oyster Point Pharma, Inc. (OYST:NASDAQ), 38.56%
- Phunware, Inc. (PHUN:NASDAQ), 38.33%
- Monopar Therapeutics Inc. (MNPR:NASDAQ), 32.55%
- Funko, Inc. (FNKO:NASDAQ), 28.66%
- ACM Research, Inc. (ACMR:NASDAQ), 27.69%
- GigaCloud Technology Inc (GCT:NASDAQ), 26.61%